Amanda Niskar on Improving the Lives of Patients with Arthritis

For almost 70 years, the Arthritis Foundation has initiated and supported scientific discoveries that improve health outcomes for people with arthritis. Research holds the key to finding better diagnostics and treatments—and one day a cure—for more than 50 million Americans who face the daily challenges of arthritis. At the Foundation, we are focused on providing scientific leadership and direction to improve everyday life for people with arthritis and to find a cure.   Information from the Medicines in Development report issued by the Pharmaceutical Research Manufacturers of America (PhRMA), about medicines that are in clinical trials or under review by the Food and Drug Administration, is a welcome sign for people with arthritis who are looking for relief.   The Arthritis Foundation is also proud to be part of the Accelerating Medicines Partnership (AMP), a groundbreaking partnership between the National Institutes of Health, several nonprofit disease foundations, 10 biopharmaceutical companies and PhRMA, which began this year. The initiative will start with three- to five-year pilot projects focused on the autoimmune diseases, such as rheumatoid arthritis (RA) and lupus.    For everyone affected by arthritis and musculoskeletal diseases, the medicines in development are offering hope and direct opportunities to new treatments previously unavailable. With greater awareness, faster approvals by the FDA of new medications and continued research and development of new ...
Source: PHRMA - Category: Pharmaceuticals Authors: Source Type: news